Assertio Holdings, Inc.
General ticker "ASRT" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $73.8M (TTM average)
Assertio Holdings, Inc. follows the US Stock Market performance with the rate: 39.8%.
Estimated limits based on current volatility of 3.0%: low 0.74$, high 0.79$
Factors to consider:
- Total employees count: 58 as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Business interruptions, Cybersecurity threats, Operational and conduct risks, Integration failure, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.44$, 1.18$]
- 2025-12-31 to 2026-12-31 estimated range: [0.59$, 1.45$]
Financial Metrics affecting the ASRT estimates:
- Positive: with PPE of -6.2 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 31.74 > 13.24
- Positive: 41.86 < Shareholder equity ratio, % of 42.52 <= 63.39
- Negative: negative Net income
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: negative Industry operating cash flow (median)
Short-term ASRT quotes
Long-term ASRT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $156.23MM | $152.07MM | $124.96MM |
| Operating Expenses | $116.83MM | $395.61MM | $149.44MM |
| Operating Income | $39.41MM | $-243.54MM | $-24.48MM |
| Non-Operating Income | $-8.24MM | $-10.52MM | $2.95MM |
| Interest Expense | $0.00MM | $9.92MM | $0.00MM |
| R&D Expense | $0.00MM | $2.84MM | $3.82MM |
| Income(Loss) | $31.17MM | $-254.05MM | $-21.53MM |
| Taxes | $-78.46MM | $77.89MM | $0.05MM |
| Profit(Loss)* | $109.62MM | $-331.94MM | $-21.58MM |
| Stockholders Equity | $225.72MM | $138.00MM | $121.08MM |
| Inventory | $13.70MM | $37.69MM | $38.31MM |
| Assets | $413.91MM | $286.42MM | $284.73MM |
| Operating Cash Flow | $78.60MM | $49.60MM | $26.41MM |
| Capital expenditure | $0.27MM | $0.63MM | $0.00MM |
| Investing Cash Flow | $-42.67MM | $3.10MM | $-48.91MM |
| Financing Cash Flow | $-7.79MM | $-44.20MM | $-0.35MM |
| Earnings Per Share** | $2.33 | $-4.67 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.